To further explore the role of the Toll pathway in RasV12 tumor malignancy, we inhibited several key components of Toll signaling, including Toll (Tl), tube (tub), pelle (pll), dorsal (dl), and Dorsal-related immunity factor (Dif). This evidence concerns the gene TLR4 and neoplasm.